1. Home
  2. PALI vs NUWE Comparison

PALI vs NUWE Comparison

Compare PALI & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PALI
  • NUWE
  • Stock Information
  • Founded
  • PALI 1996
  • NUWE 1999
  • Country
  • PALI United States
  • NUWE United States
  • Employees
  • PALI N/A
  • NUWE N/A
  • Industry
  • PALI Biotechnology: Biological Products (No Diagnostic Substances)
  • NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PALI Health Care
  • NUWE Health Care
  • Exchange
  • PALI Nasdaq
  • NUWE Nasdaq
  • Market Cap
  • PALI 3.8M
  • NUWE 3.9M
  • IPO Year
  • PALI N/A
  • NUWE N/A
  • Fundamental
  • Price
  • PALI $0.70
  • NUWE $0.30
  • Analyst Decision
  • PALI Strong Buy
  • NUWE Strong Buy
  • Analyst Count
  • PALI 2
  • NUWE 1
  • Target Price
  • PALI $12.00
  • NUWE $17.00
  • AVG Volume (30 Days)
  • PALI 452.9K
  • NUWE 30.4M
  • Earning Date
  • PALI 08-11-2025
  • NUWE 08-12-2025
  • Dividend Yield
  • PALI N/A
  • NUWE N/A
  • EPS Growth
  • PALI N/A
  • NUWE N/A
  • EPS
  • PALI N/A
  • NUWE N/A
  • Revenue
  • PALI N/A
  • NUWE $8,787,000.00
  • Revenue This Year
  • PALI N/A
  • NUWE $26.81
  • Revenue Next Year
  • PALI N/A
  • NUWE $48.74
  • P/E Ratio
  • PALI N/A
  • NUWE N/A
  • Revenue Growth
  • PALI N/A
  • NUWE N/A
  • 52 Week Low
  • PALI $0.60
  • NUWE $0.21
  • 52 Week High
  • PALI $4.89
  • NUWE $8.23
  • Technical
  • Relative Strength Index (RSI)
  • PALI 50.75
  • NUWE 27.56
  • Support Level
  • PALI $0.62
  • NUWE $0.26
  • Resistance Level
  • PALI $0.67
  • NUWE $0.59
  • Average True Range (ATR)
  • PALI 0.05
  • NUWE 0.09
  • MACD
  • PALI -0.00
  • NUWE -0.01
  • Stochastic Oscillator
  • PALI 59.65
  • NUWE 13.41

About PALI Palisade Bio Inc.

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

Share on Social Networks: